Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Dec-17 4:42 PM View:  | Domain Partners Vi, L.P. 10% Owner | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 1,857,040 | -- | -- | (100%) 1.86M to 0 | |
| 13-Dec-17 4:58 PM View: | Domain Associates 10% Owner | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 47,963 | -- | -- | (100%) 47.96K to 0 | |
| 11-Dec-17 3:24 PM View: | Bukofzer Stan Chief Medical Officer | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 202,500 | $1.52 | $307,800.00 | (100%) 202.5K to 0 | |
| 11-Dec-17 3:19 PM View: | Weber Eckard Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 356,688 | $1.52 | $542,166.00 | (97%) 369.19K to 12.5K | |
| 11-Dec-17 3:19 PM View: | Dere Willard H Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
| 11-Dec-17 3:18 PM View: | Wierenga Wendall D Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 17,500 | $1.52 | $26,600.00 | (100%) 17.5K to 0 | |
| 11-Dec-17 3:25 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 300,000 | $1.52 | $456,000.00 | (100%) 300.0K to 0 | |
| 11-Dec-17 3:25 PM View: | Kjellson Nina S Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
| 13-Dec-17 4:32 PM View: | Domain Partners Viii, L.P. 10% Owner | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 988,285 | -- | -- | (100%) 988.28K to 0 | |
| 11-Dec-17 3:19 PM View: | Vanlent Anne Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
| 11-Dec-17 3:24 PM View: | James Steven P Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
| 11-Dec-17 3:23 PM View: | Byrnes Michael CFO and Treasurer | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 163,000 | $1.52 | $247,760.00 | (100%) 163.0K to 0 | |
| 11-Dec-17 3:19 PM View: | Weber Eckard Director | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
| 13-Dec-17 4:38 PM View: | Dp Viii Associates, L.P. 10% Owner | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 7,333 | -- | -- | (100%) 7.33K to 0 | |
| 13-Dec-17 4:52 PM View: | Dp Vi Associates, L.P. 10% Owner | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 15,731 | -- | -- | (100%) 15.73K to 0 | |
| 22-Jun-17 4:41 PM View: | Weber Eckard Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 4% 356.67K to 369.17K | |
| 22-Jun-17 4:42 PM View: | Dere Willard H Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 22-Jun-17 4:42 PM View: | Wierenga Wendall D Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 250% 5.0K to 17.5K | |
| 22-Jun-17 4:40 PM View: | Kjellson Nina S Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 22-Jun-17 4:40 PM View: | Vanlent Anne Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 22-Jun-17 4:41 PM View: | James Steven P Director | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 30-Mar-17 5:16 PM View: | Bukofzer Stan Chief Medical Officer | Tranzyme, Inc. (OCRX) | 29-Mar-17 | Grant | 200,000 | -- | -- | 8000% 2.5K to 202.5K | |
| 30-Mar-17 5:15 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 29-Mar-17 | Grant | 230,000 | -- | -- | 329% 70.0K to 300.0K | |
| 30-Mar-17 5:16 PM View: | Byrnes Michael CFO and Treasurer | Tranzyme, Inc. (OCRX) | 29-Mar-17 | Grant | 150,000 | -- | -- | 1154% 13.0K to 163.0K | |
| 28-Mar-17 4:06 PM View: | Byrnes Michael CFO and Treasurer | Tranzyme, Inc. (OCRX) | 28-Mar-17 | Market Purchase | 3,000 | $1.28 | $3,854.40 | 30% 10.0K to 13.0K | 39% |
| 08-Dec-16 4:18 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 07-Dec-16 | Market Purchase | 7,000 | $2.14 | $14,980.00 | 11% 63.0K to 70.0K | (16%) |
| 30-Dec-16 6:51 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 31-Oct-16 | Acquisition (other) | 14,328 | -- | -- | 2% 848.22K to 862.55K | |
| 30-Dec-16 6:51 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 31-Oct-16 | Disposition (other) | 848,222 | -- | -- | (98%) 862.55K to 14.33K | |
| 17-Oct-16 8:28 AM View: | Bukofzer Stan Chief Medical Officer | Tranzyme, Inc. (OCRX) | 13-Oct-16 | Market Purchase | 2,500 | $2.64 | $6,597.50 | 100% 0 to 2.5K | (32%) |
| 30-Dec-16 6:51 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 12-Sep-16 | Exercise (in-the money or at-the-money) | 22,264 | $0.67 | $14,916.90 | 3% 832.47K to 854.73K | |
| 30-Dec-16 6:51 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 12-Sep-16 | Market Sale | 6,512 | $2.29 | $14,925.50 | (< 1%) 854.73K to 848.22K | 22% |
| 10-Feb-17 10:00 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 29-Jul-16 | Market Sale | 11,969 | $2.53 | $30,281.60 | (100%) 11.97K to 0 | 29% |
| 13-Jul-16 8:32 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 11-Jul-16 | Option Exercise | 11,969 | $1.26 | $15,080.90 | 100% 0 to 11.97K | |
| 07-Mar-16 8:08 AM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 04-Mar-16 | Market Purchase | 3,000 | $3.19 | $9,570.00 | 5% 60.0K to 63.0K | (44%) |
| 25-Jan-16 5:19 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 22-Jan-16 | Market Purchase | 10,000 | $2.38 | $23,800.00 | 20% 50.0K to 60.0K | (25%) |
| 19-Jan-16 8:14 AM View: | Byrnes Michael CFO and Treasurer | Tranzyme, Inc. (OCRX) | 15-Jan-16 | Market Purchase | 3,500 | $2.07 | $7,245.00 | 54% 6.5K to 10.0K | (14%) |
| 19-Jan-16 8:14 AM View: | Aggarwal Gaurav Chief Business Officer | Tranzyme, Inc. (OCRX) | 15-Jan-16 | Market Purchase | 10,000 | $2.15 | $21,500.00 | 100% 10.0K to 20.0K | (17%) |
| 19-Jan-16 8:14 AM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 15-Jan-16 | Market Purchase | 10,000 | $2.08 | $20,800.00 | 25% 40.0K to 50.0K | (14%) |
| 06-Jan-16 4:03 PM View: | Weber Eckard Director | Tranzyme, Inc. (OCRX) | 04-Jan-16 | Gift | 11,969 | -- | -- | (3%) 368.66K to 356.69K | |
| 06-Jan-16 4:03 PM View: | Weber Eckard Director | Tranzyme, Inc. (OCRX) | 04-Jan-16 | Option Exercise | 11,969 | $0.92 | $11,011.50 | 3% 356.69K to 368.66K | |
| 24-Jun-15 4:44 PM View: | Wierenga Wendall D Director | Tranzyme, Inc. (OCRX) | 23-Jun-15 | Market Purchase | 5,000 | $3.71 | $18,550.00 | 100% 0 to 5.0K | (52%) |
| 07-May-15 5:19 PM View: | Patni Rajiv Chief Development Officer | Tranzyme, Inc. (OCRX) | 07-May-15 | Market Purchase | 5,050 | $3.97 | $20,048.50 | 100% 0 to 5.05K | (55%) |
| 06-May-15 6:02 PM View: | Aggarwal Gaurav Chief Business Officer | Tranzyme, Inc. (OCRX) | 06-May-15 | Market Purchase | 7,500 | $3.62 | $27,150.00 | 300% 2.5K to 10.0K | (51%) |
| 06-May-15 6:03 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 06-May-15 | Market Purchase | 30,000 | $3.73 | $111,900.00 | 300% 10.0K to 40.0K | (52%) |
| 06-May-15 6:03 PM View: | Byrnes Michael CFO and Treasurer | Tranzyme, Inc. (OCRX) | 06-May-15 | Market Purchase | 2,500 | $3.61 | $9,025.00 | 62% 4.0K to 6.5K | (50%) |
| 02-Oct-14 4:16 PM View: | Byrnes Michael VP, Finance & Treasurer | Tranzyme, Inc. (OCRX) | 01-Oct-14 | Market Purchase | 2,000 | $4.81 | $9,620.00 | 100% 2.0K to 4.0K | (63%) |
| 15-Jul-14 4:05 PM View: | Tetlow Sharon Acting CFO & Treasurer | Tranzyme, Inc. (OCRX) | 11-Jul-14 | Market Purchase | 3,000 | $5.83 | $17,487.00 | 100% 0 to 3.0K | (69%) |
| 15-Jul-14 4:05 PM View: | Grais Linda S President and CEO Director | Tranzyme, Inc. (OCRX) | 11-Jul-14 | Market Purchase | 10,000 | $5.93 | $59,280.00 | 100% 0 to 10.0K | (70%) |
| 20-Mar-14 6:22 PM View: | Powell Michael Director | Tranzyme, Inc. (OCRX) | 18-Mar-14 | Disposition (other) Duplicate | 410,022 | -- | -- | (33%) 1.24M to 832.47K | |
| 20-Mar-14 6:17 PM View: | Sofinnova Venture Partners ... 10% Owner | Tranzyme, Inc. (OCRX) | 18-Mar-14 | Disposition (other) | 410,022 | -- | -- | (33%) 1.24M to 832.47K |
